Novo Nordisk (United Kingdom)
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Novo Nordisk (United Kingdom), United Kingdom, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
67%
Total
Publications
856
Total Open
Publications
572
Total
Citations
30K
Open Access
Percentage
67%
Total
Publications
856
Total Open
Publications
572
Total
Citations
30K
Breakdown
Publisher Open
18%
Both
30%
Other Platform Open
19%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
165
Hybrid 32%
131
No Guarantees 27%
108
Other Platform Open
Domain 56%
236
Institution 48%
200
Preprint 27%
115
Other Internet 23%
96
Public 3%
14
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 238 |
DOI | Other Internet | 83 |
doaj.org OAI-PMH Repository | Institution | 75 |
medRxiv | Preprint | 54 |
Unknown Repository | Other Internet | 45 |
University of Cambridge | Institution | 43 |
University of Bristol | Institution | 39 |
Research Square | Preprint | 30 |
bioRxiv | Preprint | 27 |
Imperial College London | Institution | 26 |